BioCardia Inc. (BCDA)
NasdaqCM: BCDA
· リアルタイム株価 · USD
0.97
+0.04 (4.30%)
終値時点: Aug 14, 2026, 3:59 PM
0.98
+0.43%
時間外: 7:51 PM
BioCardia Inc. (BCDA) Stock Price, Analysis & Data
4.30% (1D)
BCDAについて
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It also ...
セクター Healthcare
IPO日 Nov 13, 1996
従業員数 17
上場取引所 NasdaqCM
ティッカー BCDA
ウェブサイト https://www.biocardia.com
決算サプライズ
BioCardiaはAug 12, 2026に四半期決算を発表しました:
2ページ中1ページ

